DISEASE INDICATIONS: Gynaecological Cancer

MANUFACTURER: Tesaro UK Limited

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Zejula (niraparib) is a drug used for the maintenance treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients who have responded to platinum-based chemotherapy.